Revised net sales to 12,500 hundred million yen (previous forecast: 11,600 hundred million yen), operating income to 1,100 million yen, ordinary income to 1,250 million yen, net income attributable to owners of parent to 950 million yen, and net income per share to 115.23 yen. This is not a dividend increase or a change to the year-end dividend forecast; overall profitability is expected to improve due to supply-demand improvement and the start of mass production of newly developed products.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4360","jir_company_name":"MANAC Chemical Partners Co.,Ltd","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-13","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/4360-20261113-02.pdf","jir_short_summary":"Revised net sales to 12,500 hundred million yen (previous forecast: 11,600 hundred million yen), operating income to 1,100 million yen, ordinary income to 1,250 million yen, net income attributable to owners of parent to 950 million yen, and net income per share to 115.23 yen. This is not a dividend increase or a change to the year-end dividend forecast; overall profitability is expected to improve due to supply-demand improvement and the start of mass production of newly developed products.","jir_summary":"### Summary of Revision to Earnings Guidance\nIncreased demand for pharmaceutical intermediates and active pharmaceutical ingredients, along with the start of mass production and increased overseas sales of newly developed semiconductor-related products, are expected to contribute to net sales exceeding the previous forecast. Profit estimates have also become reasonably calculable, and revised forecasts for each profit item are being disclosed. Both net sales and profits are expected to exceed the results of the previous fiscal year.\n\n### Outlook and Cautionary Matters\nThis document contains forecasts based on information available at the time and actual results may differ depending on future market trends. The reasons for the revision include increased demand and the start of mass production of newly developed products, as well as expansion in overseas markets.","jir_financial_highlights":"Net Sales: 12,500 (Previous forecast 11,600 \u2192 Revised this time 12,500 hundred million yen)\nOperating Income: 1,100 (Previous forecast 0 \u2192 Revised this time 1,100 million yen)\nOrdinary Income: 1,250 (Previous forecast 0 \u2192 Revised this time 1,250 million yen)\nNet Income Attributable to Owners of Parent: 950 (Previous forecast 0 \u2192 Revised this time 950 million yen)\nNet Income per Share: 115.23 (Previously Unknown \u2192 Revised this time 115.23 yen)","jir_category":"","jir_hashtags":"#NoCompanyTagUsedPractically","jir_key_figures":"Net Sales: 12,500 hundred million yen\nOperating Income: 1,100 million yen\nOrdinary Income: 1,250 million yen","jir_meta_title":"MANAC Chemical Partners Co.,Ltd Revises Earnings Guidance\uff5cFiscal Year Ending March 2027","jir_meta_description":"MANAC Chemical Partners Co.,Ltd has revised its full-year consolidated earnings guidance for the fiscal year ending March 2027. Net sales are revised to 12,500 hundred million yen, operating income to 1,100 million yen, ordinary income to 1,250 million yen, net income to 950 million yen, and net income per share to 115.23 yen. Improvements in supply-demand and the start of mass production for new products contributed to the revision.","jir_og_title":"MANAC Chemical Partners Co.,Ltd Revises Earnings Guidance\uff5cFiscal Year Ending March 2027","jir_og_description":"Due to supply-demand improvements and the start of mass production for newly developed products, the company has revised up its full-year consolidated earnings guidance for the fiscal year ending March 2027. Net sales: 12,500 hundred million yen; net income: 950 million yen; EPS: 115.23 yen.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59749,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"earnings_guidance","footnotes":""},"sector":[],"importance":[],"class_list":["post-153070","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n